Delphine Collin is a prominent inventor based in New Milford, Connecticut. She has made significant contributions to the field of pharmaceuticals, particularly in the modulation of ROR gamma. With a total of three patents to her name, her work is paving the way for advancements in medical treatments.

Latest Patents

Her latest patents include "Substituted pyrazino[2,3-b]pyrazines and pyrazino[2,3-c]pyridazines as modulators of ROR gamma." This invention encompasses compounds of a specific formula that are suitable for the modulation of ROR gamma and the treatment of diseases related to this modulation. Additionally, she has developed processes for making these compounds and pharmaceutical preparations containing them.

Career Highlights

Delphine Collin is currently employed at Boehringer Ingelheim International GmbH, where she continues to innovate in her field. Her work is characterized by a strong focus on pharmaceutical applications and the development of new compounds that can significantly impact healthcare.

Collaborations

Throughout her career, Delphine has collaborated with notable colleagues, including Robert Owen Hughes and Michael Robert Turner. These partnerships have enhanced her research and contributed to the success of her inventions.

Conclusion

Delphine Collin is a trailblazer in the pharmaceutical industry, with her innovative patents and collaborative efforts driving advancements in medical treatments. Her contributions are vital to the ongoing development of effective therapies.

This text is generated by artificial intelligence and may not be accurate.